Pediatrix Medical Group Q3 revenue slightly beats on volume and pricing

Overview

• US physician services provider's Q3 revenue slightly beat analyst expectations, rising 1.7% yr/yr

• Q3 adjusted EBITDA beat analyst expectations

• Company says results driven by volume and pricing ahead of expectations

Outlook

• Pediatrix expects full-year 2026 Adjusted EBITDA between $290 mln and $300 mln

Result Drivers

• VOLUME AND PRICING - Co said Q3 results were driven by both patient volume and pricing performing ahead of expectations, per CEO Mark S. Ordan

• RECENT ACQUISITIONS - Co said growth in non-same unit activity was driven by recent acquisitions, partially offset by practice dispositions

• FAVORABLE PAYOR MIX - Co said same-unit revenue from net reimbursement-related factors increased due to a favorable shift in payor mix, higher administrative fees from hospital partners and higher patient acuity, primarily in neonatology

Company press release: ID:nBw38ThCKa

Key Details

*Applies to a deviation of less than 1%; not applicable for per-share numbers.

Analyst Coverage

• The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy", 6 "hold" and no "sell" or "strong sell"

• The average consensus recommendation for the healthcare facilities & services peer group is "buy."

• Wall Street's median 12-month price target for Pediatrix Medical Group Inc is $28.00, about 3.1% below its October 28 closing price of $28.91

• The stock recently traded at 12 times the next 12-month earnings vs. a P/E of 11 three months ago

Reuters Recommended Reads

• Oct 27 - Universal Health warns of possible impact to annual results from Medicaid changes; Q3 revenue slightly beats

• Oct 27 - Ensign Group Q3 adjusted EPS beats estimates, revenue up on higher occupancy rates

• Oct 27 - HCA signals flat 2027 earnings as Medicaid payments drop; shares slide

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)